TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioInvent International AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,890
|
6,440
|
29,306 |
| Financial expenses |
57
|
138
|
71 |
| Earnings before taxes |
-37,369
|
-29,749
|
-3,819 |
| EBITDA |
-41,010
|
-33,340
|
-4,576 |
| Total assets |
86,122
|
126,188
|
153,861 |
| Current assets |
82,115
|
102,133
|
97,415 |
| Current liabilities |
8,289
|
6,842
|
7,847 |
| Equity capital |
77,118
|
118,036
|
144,328 |
| - share capital |
1,146
|
1,186
|
1,168 |
| Employees (average) |
112
|
104
|
89 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
89.5%
|
93.5%
|
93.8% |
| Turnover per employee |
35
|
62
|
329 |
| Profit as a percentage of turnover |
-960.6%
|
-461.9%
|
-13.0% |
| Return on assets (ROA) |
-43.3%
|
-23.5%
|
-2.4% |
| Current ratio |
990.7%
|
1492.7%
|
1241.4% |
| Return on equity (ROE) |
-48.5%
|
-25.2%
|
-2.6% |
| Change turnover |
-2,331
|
-22,951
|
27,564 |
| Change turnover % |
-37%
|
-78%
|
1582% |
| Chg. No. of employees |
8
|
15
|
10 |
| Chg. No. of employees % |
8%
|
17%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.